Other
Opioid Consumption
0
Pipeline Programs↗
4
Active Trials↗
0
Companies Involved↗
Opioid Consumption is an early-stage landscape with 0 programs across 0 companies.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
20
clinical trials
Completed13 · 65%
Not yet recruiting2 · 10%
Unknown status2 · 10%
Recruiting1 · 5%
Withdrawn1 · 5%
Active, not recruiting1 · 5%
Clinical Trials
Trial Activity
20 trials
Nasal Dexmedetomidine Versus Systemic Infusion Dexmedetomidine in Reducing Intraoperative Opioid Consumption in Nasal Endoscopic Surgeries
Not yet recruiting·—·Phase 1·NCT07012213·50 enrolled
Intravenous Acetaminophen to Reduce Post-operative Opioid Consumption
Not yet recruiting·—·Phase 4·NCT06923540·140 enrolled
Gabapentin Regimens and Their Effects on Opioid Consumption
Completed·—·Phase 4·NCT03334903·77 enrolled
Effect of Opioid Free Anesthetic on Post-Operative Opioid Consumption After Laparoscopic Bariatric Surgery
Completed·—·Phase 3·NCT04081545·181 enrolled
Decrease Opioid Consumption With Intra-Venous (IV) Acetaminophen After Colorectal Surgery (DOCIVA)
Completed·—·N/A·NCT02804633·105 enrolled
The Effect of Intraoperative Ketamine on Opioid Consumption and Pain After Spine Surgery in Opioid-dependent Patients
Completed·—·Phase 4·NCT02085577·147 enrolled
Scalp Nerve Block and Opioid Consumption in Brain Surgery
Completed·—·Phase 4·NCT02057367·100 enrolled
Duloxetine Role in Reducing Opioid Consumption After Thoracotomy
Completed·—·Phase 4·NCT03618225·60 enrolled
Page 1 of 2
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)